Dr. Velasco explains research with cannabinoids for cancer treatment

Dr Guillermo Velasco from the Complutense University in Madrid talks about the upcoming independent clinical trials that are due to take place in Spain in 2018. The trials are being funded by donations from the Medical Cannabis Bike Tour, a non-profit organization that raises money through sponsorship of its annual bike ride.

Dr Velasco describes how the clinical trials will be conducted (based on a study of 30 patients), using the cannabinoids, Tetrahydrocannabinol (THC) and cannabidiol (CBD).
Dr Velasco will be overseeing the trials that are being conducted with the support of the Spanish Group on Neuro Oncological Investigation, GEINO. Current scientific evidence supports that cannabis derivatives may provide relief to patients suffering from gliomas.

Published studies have demonstrated that the active principles of cannabis promote cancer cell death. Pre-clinical work performed over the past few years by the Complutense University team, has proved that the active principles of cannabis have anticancer activity in animal and cell models of glioma.